Introduction
In vertebrates, biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) eicosapentaenoic (EPA; 20:5n-3) and arachidonic (20:4n-6) acids from 18:3n-3 and 18:2n-6, respectively, requires the sequential activity of a Δ6 fatty acyl desaturase (FAD), an elongase and Δ5 FAD (Cook, 1996) . Synthesis of docosahexaenoic acid (DHA; 22:6n-3) requires two further elongation steps, a second Δ6 desaturation and peroxisomal chain shortening (Sprecher, 2000) , However, the production of LC-PUFA from C18 fatty acids is inefficient in humans (Salem et al., 1999; Brenna, 2002; Burdge and Calder, 2005) . This fact underpins the well-known phenomenon that increasing our dietary intake of EPA and DHA has beneficial effects in a number of inflammatory and pathological conditions, including cardiovascular and neurological diseases (Brouwer et al., 2006; Eilander et al., 2007; Ruxton et al., 2007) , and the much greater efficacy of fish oil containing these LC-PUFA than linseed/flax oil, rich in 18:3n-3, in intervention studies (Torrejon et al., 2008; Brenna et al., 2009 ).
Fish are unique sources of the omega-3 or n-3 LC-PUFA, EPA and DHA, in the human diet (Givens and Gibbs, 2006) , and an increasing proportion of fish are now farmed (FAO, 2009 ). However, sustainable development of aquaculture to produce the fish required for the burgeoning human population requires n-3 LC-PUFA-rich fish oil in the feed to be replaced by vegetable oils that are devoid of LC-PUFA, with consequences for fish lipid metabolism and human health (Sargent et al., 2002) . The ability of fish to convert 18:3n-3 to EPA and DHA is also rather inefficient and our overarching hypothesis is that understanding the molecular basis of LC-PUFA biosynthesis and its regulation in fish will allow us to manipulate and optimise the activity of the pathway to enable efficient and effective use of vegetable oils in aquaculture while maintaining the nutritional quality of farmed fish.
Our understanding of the biochemical and molecular mechanisms of LC-PUFA biosynthesis in fish has advanced considerably in recent years (Tocher, 2003; Tocher et al., 2003a) . Several FADs have been characterised in various fish species, and all are Δ6 FADs (Zheng et al., 2004 (Zheng et al., , 2005a (Zheng et al., , 2009 Tocher et al., 2006) , except for a zebrafish bifunctional Δ6/Δ5 FAD (Hastings et al., 2001 ) and an Atlantic salmon (Salmo salar) Δ5 FAD (Hastings et al., 2005) . To date no Δ5 FAD has been isolated from a marine fish species and, supported by biochemical studies in fish cell lines (Ghioni et al., 1999; Tocher and Ghioni, 1999) , this has led to the hypothesis that some groups of fish may be unable to biosynthesise LC-PUFA because they lack specific genes in the pathway (Leaver et al., 2008a) . However, Δ6 FADs cDNAs have been cloned from all fish species studied so far, and all showed significant 4 activity in heterologous yeast expression systems. In contrast, Δ6 desaturation activity and expression of Δ6 FAD are very low in Atlantic cod (Gadus morhua) tissues compared to the activity and expression of Δ6 FAD in salmon tissues (Tocher et al., 2006) . Furthermore, Δ6 FAD expression and activity are under nutritional regulation in freshwater and salmonid fish.
The activity of the LC-PUFA pathway in carp cells was increased by essential fatty acid (EFA)-deficiency (Tocher and Dick, 1999) , and modulated by different C18 PUFA (Tocher and Dick, 2000) . In vivo dietary trials have shown that activity of the LC-PUFA biosynthetic pathway is increased in freshwater and salmonid fish fed vegetable oils rich in C18 PUFA compared to fish fed fish oil, rich in EPA and DHA (Tocher et al., 1997 (Tocher et al., , 2002 (Tocher et al., , 2003b .
Expression of Δ6 FAD mRNA was reduced in salmon fed diets containing fish oil, rich in EPA and DHA, in comparison to fish fed diets containing vegetable oils lacking LC-PUFA (Zheng et al., 2005a,b; Leaver et al., 2008b; Taggart et al., 2008) . Again, in contrast, there was little difference in Δ6 FAD expression and activity in cod fed diets containing either vegetable or fish oil (Tocher et al., 2006) . Thus cod may be deficient, both in critical LC-PUFA biosynthetic genes and in the expression levels and regulation of Δ6 FAD compared to salmon.
In the present study, we have compared the sequences of the putative promoter regions for the Δ6 FAD genes of Atlantic salmon and Atlantic cod, and tested these regions for their ability to drive reporter gene expression in a transfected fish cell line. This enabled delineation of the regions of the promoters that drive both basal expression and confer responsiveness to LC-PUFA. Comparison of these regions with the sequences of corresponding regions of Δ6 FAD genes from other fish, an amphibian and human indicated remarkably high conservation of sequence elements implicated in regulating Δ6 FAD in humans. Atlantic salmon, in addition, possess a site with similarity to that recognised by Sp1 transcription factor that was responsible for higher expression of the salmon Δ6 FAD gene compared to cod, which lacked the Sp1 site.
Materials and methods

Genomic organization and promoters of salmon and cod FAD genes
Atlantic salmon and cod genomic DNA libraries were constructed in lambda FIX II (Stratagene, La Jolla, CA, USA). The respective DNA libraries were probed with full-length 5 salmon (GenBank accession no. AY458652) and cod ∆6 FAD cDNAs (Accession no. DQ054840). Inserts of positive recombinant phages were isolated and subcloned into the pBluescript II KS vector for sequencing (Stratagene, La Jolla, CA, USA). The full desaturase genomic nucleotide sequences were assembled using BioEdit version 5.0.6 (Tom Hall, Department of Microbiology, North Carolina State University, USA). The gene structures and the upstream sequences were identified and confirmed by comparing the genomic sequences with the relevant FAD cDNA sequences reported previously (Zheng et al. 2005a; Tocher et al. 2006 ).
LC-PUFA synthesis in Atlantic salmon cell line (AS)
The activity of the LC-PUFA synthesis pathway was determined in the Atlantic salmon cell line (AS) as described in detail previously (Ghioni et al., 1999) . Briefly, AS cells were seeded into 75 cm 2 flasks in medium containing 10 % delipidated (charcoal/dextran-treated) fetal bovine serum (dFBS; HyClone, Logan, Utah, USA) and grown to 80% confluence. Cultures were supplemented with 50 µM EPA or DHA, with control cultures receiving the same volume of ethanol carrier alone and, 24 h later, [1-14 C]18:3n-3 was added as a bovine serum albumin (BSA) complex (0.25 µCi/flask). After a further 24 h, medium was aspirated, cultures washed with 5 ml phosphate buffered saline (PBS), cells dissociated with 0.05 % trypsin/0.02 % EDTA, harvested in 5 ml PBS and centrifuged at 300 g for 5 min at 4 °C.
Cells were washed with 5 ml PBS containing 1 % fatty acid free-BSA, prior to extraction with 5 ml ice-cold chloroform/methanol (2:1, v/v) containing 0.01 % butylated hydroxytoluene as antioxidant, according to Folch et al. (1957) . Fatty acid methyl esters were prepared by acidcatalysed transmethylation and separated by argentation chromatography on TLC plates impregnated with 2 g silver nitrate in 20 ml acetonitrile and activated at 110 °C for 30 min as described previously (Ghioni et al., 1999 calculated from the ratio of firefly:Renilla luciferase for each construct, and then normalized to the activity of pGL4.10 with no insert (no insert control; NIC) luciferase in the presence or absence of EPA.
Site-directed mutagenesis
Mutations were performed using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's protocol with mutations confirmed by sequence analysis. For salmon FAD, the construct SD2 was used as wild type and for cod FAD, the construct CD34 was used, and five mutants were produced from each (Table 2 ). The selection of sites for mutation was based on an alignment of the salmon and cod sequences across the region under study, which indicated areas of sequence conservation, and also by the use of an in silico online Patch TM tool with the TRANSFAC ® Professional database to predict potential transcription factor binding sites.
Electrophoretic mobility shift assay (EMSA)
Complementary sense and anti-sense oligonucleotides (Table 1, single strand only is shown) were labelled separately with Biotin 3′ End DNA Labeling Kit (Pierce, Rockford, IL, USA). They were then annealed to produce the double strand DNA probe. Oligos SDB1 and SDA1 included salmon putative binding sites 2 and 5 (bold letters), respectively. Oligos CDC1, CDB1 and CDA1 included cod putative binding sites 3, 4 and 5 (bold letters),
respectively. Mutant sites were tested using oligonucleotides as shown in Table 2 . Nuclear extract was prepared from AS cells using the Active Motif Nuclear Extract Kit (Carlsbad, CA, USA) and protein content determined by the Quick Start Bradford Protein Assay Kit supplied by Bio-Rad Laboratories (Hercules, CA, USA). The EMSA reaction was performed with LightShift Chemiluminescent EMSA Kit (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. The binding reaction was subjected to a 5 % non-denaturing polyacrylamide gel and transferred to a nylon membrane. The biotin end-labeled DNA was detected using a streptavidin-horseradish peroxidase conjugate and a chemiluminescent substrate. The signal was then detected by autoradiography with CL-XPosure x-ray film (Pierce, Rockford, IL, USA).
Results
Organisation of salmon, cod and other vertebrate Δ6 FAD genes
Previously, we reported the full-length cDNAs for salmon and cod Δ6 FADs, which
showed they contained open reading frames of 1365 and 1344 bp, coding proteins of 454 and 447 aa, respectively (Zheng et al., 2005a; Tocher et al., 2006) . The putative transcription start 8 sites for these two genes were identified according to the published 5'UTR sequences, which were obtained by 5' SMART RACE PCR. The salmon and cod ∆6 FAD genes both consisted of 13 exons that spanned 12090 bp and 5106 bp of genomic DNA (GenBank accession numbers AY736067 and FJ859898), respectively ( In each case these genes were organised similarly to the cod and salmon genes, with an initial non-coding exon followed by 12 coding exons, encoding a complete Δ6 FAD homologue. In the case of the amphibian Xenopus tropicalis an annotated Δ6 desaturase was not clearly recognisable, however a search using the salmon cDNA and TBLASTX identified 12 coding exons for a Δ6 FAD in this species. It was not possible to identify any 5' noncoding exons.
AS cells as a model system for LC-PUFA biosynthesis
AS cells have been previously shown to have a fully functional LC-PUFA synthesis pathway (Ghioni et al., 1999) indicating that the Δ6 FAD gene should be expressed in this cell line. In order to determine whether LC-PUFA biosynthesis in AS cells is regulated by fatty acids, the pathway was assayed by determining the desaturation of [1-14 C]18:3n-3 in the presence or absence of EPA and DHA. Addition of EPA or DHA to AS cells cultured in dFBS showed that LC-PUFA synthetic activity was significantly reduced by the presence of the LC-PUFA (Fig.2) . Thus, EPA was chosen as a potential modulator of FAD expression in AS cells growing in lipid-deficient media.
Promoter deletion analysis
To determine the minimal FAD gene sequences that are sufficient to direct transcription, the DNA fragment encompassing upstream, untranscribed exon and initiation codon 9 sequence, and deletions thereof, was fused to a promoterless luciferase reporter gene and examined for the ability to mediate basal transcription. Transfection of AS cells in dFBS with a series of salmon promoter deletion constructs showed that maximal promoter activity was evident when up to 546 nucleotides upstream of the transcription start site (TSS) were included in the construct (SD2) (Fig.1) . A deletion with 321 nucleotides upstream of the TSS (SD21) exhibited much reduced activity, although still significantly higher than all other deletions, which ranged from 321 nucleotides upstream, to 726 downstream of the TSS. The deletion constructs were also tested in parallel for response to LC-PUFA, with EPA treatment causing a significant reduction in promoter activity of both the SD2 and SD21 constructs (36 and 26% reduction, respectively). Deletions beyond 321 nucleotides upstream of the TSS showed general reductions of around 15% after EPA treatment, although these were not statistically significant when compared to the same constructs in the absence of EPA. A similar experiment conducted with deletion constructs from Atlantic cod showed that deletion of more than 167 nucleotides upstream of the TSS greatly reduced activity (Fig.1) . No further decreases in activity were observed in further deletions up to 983 nucleotides downstream of the TSS. Although EPA treatment significantly reduced activity in some of the cod promoter deletions, the reductions were more variable and did not show a clear pattern as in the salmon constructs.
Promoter mutagenesis
The sequences of the salmon and cod Δ6 FAD fragments identified by promoter deletion were subjected to further in silico analysis that showed it was possible to align an area with similarity across all species, with the areas of identity across all genes corresponding to possible nuclear factor Y (NF-Y) and sterol regulatory element binding protein (SREBP) sites (Fig.3) . Candidate transcriptional regulatory sequences were selected based primarily on the effects of promoter deletion, with focus on sequences that varied between salmon and cod Δ6
FADs, and promoter activity investigated in AS cells transfected with mutants targeting these sequences (Fig. 4) . For salmon Δ6 FAD, mutations at site 2 and site 5 caused significant reductions of promoter activity of 38% and 73% of the wild type activity, respectively (Fig.5 ).
For cod Δ6 FAD, mutations in sites 3, 4 and 5 caused significant reductions of promoter activity of 48 %, 60 % and 65 % of the wild type activity, respectively (Fig. 6) . Mutation of various other sites had no significant affects on promoter activity.
EMSA
In order to show that regulatory sites in the salmon and cod promoters were capable of binding factors present in AS cell nuclei, EMSAs were performed using synthetic oligonucleotides corresponding to the sequences of the putative binding sites and AS cell nuclear extracts. The putative binding sites 2 and 5 for salmon, and sites 3, 4 and 5 for cod were investigated based on the results of the mutagenesis experiment. However, no shifts were observed using salmon site 2 and cod site 4 and site 5 probes (data not shown), but DNA-protein complexes were observed with salmon site 5 (Fig.7 , lane 2) and with cod site 3 (Fig.8, lane 2) . Salmon site 5 was the potential Sp1 site and cod site 3 was a possible CCAAT/enhancer binding protein (C/EBP) alpha site. A 200-fold molar excess of competitor DNA, unlabeled consensus oligonucleotides (lanes 3) completely inhibited the complex formations in both cases. The complexes were not observed when mutated oligonucleotide probes were used (lanes 4, 5 and 6). Similar results were obtained when the nuclear extract was prepared using cells cultured in dFBS without or with EPA (lanes 7 and 8), or more nuclear extract was used (lane 9, Fig.7 ).
Discussion
The LC-PUFA EPA was chosen as a know modulator of FAD expression in salmon, and the AS cell line was chosen as the cell system in which to study the salmon and cod promoters, based on results of several previous studies. The activity of the LC-PUFA biosynthesis pathway was significantly lower in liver and intestine from salmon being fed EPA and DHA in the form of fish oil compared to fish fed vegetable oils that are devoid of LC-PUFA (Tocher et al., 1997 (Tocher et al., , 2003c . There is also a significant correlation between the activity of the LC-PUFA biosynthetic pathway and dietary n-3 LC-PUFA levels (Tocher et al., 2003b) . Moreover several studies have demonstrated that the expression of Δ6 FAD mRNA was lower in livers of salmon fed fish oil compared to fish fed vegetable oils (Zheng et al., 2005a,b; Leaver et al., 2008b; Taggart et al., 2008) . Therefore, there is strong evidence that the effects of dietary EPA and DHA in salmon are mediated through effects on the transcription of Δ6 FAD. Since the LC-PUFA biosynthesis pathway in AS cells has been previously investigated in some detail (Tocher and Sargent, 1990; Ghioni et al., 1999) FADs consisted of 13 exons, the first of which was non-coding followed by 12 coding exons.
In contrast, human Δ5 and Δ6 desaturases (FADS1 and FADS2, respectively) consisted of 12 coding exons and no 5' non-coding exons (Marquardt et al., 2000) . The structure of Xenopus Δ6 FAD is less certain, but based on available EST sequences, it may also lack the 5' noncoding exon found in the fish species. Despite this difference, comparison of the sequences immediately 5' of the first exon for all these genes, showed an area with similarity across all species that included NF-Y and SREBP sites (Nara et al., 2002) . However, the specific aim of the present study was to determine if there were differences in the promoters of salmon and cod Δ6 FADs that could account for, or contribute to, the differences in gene expression and enzymatic activity observed between these species (Tocher et al., 2006) , and therefore studies were targeted to identify promoter sequences that were not conserved between salmon and cod.
The promoter deletion studies clearly defined regions that had transcriptional activity for both salmon and cod Δ6 FADs. The salmon promoter contained two sites, sites 2 and 5, which when absent from the deletion construct, either following deletion or by mutation, resulted in significantly lower activity. Sites 2 and 5 contain consensus sequences for a nuclear receptor half site and for the ubiquitous general transcription factor Sp1, respectively, with sites for the latter also demonstrated in human Δ6 FADS2 gene promoter (Tang et al., 2003) . Although deletion of these sites considerably reduced transcriptional activity, they did not abolish it, nor did they have a significant effect on the relative reduction in activity caused by EPA. This suggests that Sp1 particularly may be important for constitutive expression of salmon Δ6
12
FAD, but is not responsible for the suppressive effect of EPA. Therefore, the sequence(s) driving the effect of EPA must reside in a region less than 315 nucleotides upstream of the salmon Δ6 FAD TSS.
In comparison to salmon, the cod promoter showed less activity but a region with significant promoter activity could still be defined. It was noteworthy that this region did not contain an obvious Sp1 binding site. Consistent with the low activity of the cod gene promoter observed here, Δ6 FAD is expressed at considerably lower levels in cod and other marine fish compared to salmon (Tocher et al., 2003a (Tocher et al., , 2006 , and Δ6 desaturation activity is much lower in tissues of cod compared to salmon (Tocher et al., 2006) . Therefore, based on the results presented here, it is possible to speculate that this difference in constitutive or basal expression of Δ6 FAD between salmon and cod may be due the presence of an Sp1-like site in the salmon promoter, which is not present in the corresponding region of the cod. The effects of EPA on the activity of the cod Δ6 FAD promoter were not consistent, and there was no substantial evidence to suggest that EPA affected promoter activity, although this may be a consequence of a lack of assay sensitivity, given the lower overall activity of this promoter compared to salmon. Similar inconclusive results were obtained in vivo for the effects of LC-PUFA on Δ6 FAD gene expression in cod. Although, the expression of Δ6 FAD in cod appeared lower in fish fed EPA-and DHA-rich fish oil compared to cod fed vegetable oil, this was not statistically significant (Tocher et al., 2006) . For sure, only very low levels of fatty acyl desaturation activity were apparent in cod hepatocytes and enterocytes, irrespective of diet (Tocher et al., 2006) .
The effects of LC-PUFA such as EPA, on fatty acid desaturation pathways have also been studied in mammalian systems. The levels of hepatic mRNA for Δ6 and Δ5 FADs in rats fed menhaden oil (EPA and DHA) were only 25 % of those in rats fed a fat-free diet or a diet containing triolein (18:1n-9) (Cho et al., 1999) . Furthermore, a region of the human FADS2 gene promoter that is responsible for mediating transcriptional suppression by LC-PUFA has been described (Nara et al., 2002) . This region contained a sterol regulatory element (SRE) adjacent to elements that are known to bind NF-Y transcriptions factors. These sites and the SREPB transcription factor appeared to mediate the suppressive effect of LC-PUFA (Nara et al., 2002) . In an attempt to define regions of the salmon and cod desaturase genes that may also mediate the effects of LC-PUFA, the sequences were compared with that of the human FADS2 promoter, and also with putative promoter sequences for other fish and amphibian Δ6
FADs extracted from the ENSEMBL genome databases (Fig. 3) . Interestingly, a region Although to date SREBPs have not been characterised in fish species, their involvement in desaturase expression in Atlantic salmon has been previously suggested based on the increase in expression of both desaturase mRNA and an mRNA for an SREBP-like sequence following feeding of salmon diets low in LC-PUFA (Leaver et al., 2008b) , and thus the involvement of SREBP in LC-PUFA regulation of Δ6 FAD genes in salmonids and/or freshwater fish is possible (Seiliez et al., 2001; Zheng et al., 2005a,b) . Testing this possibility will be dependent on the identification and isolation of piscine SREBPs and other transcription factors. In addition however, as described above, there are differences between salmon and cod in the apparent regulation of Δ6 FAD and fatty acid desaturation by LC-PUFA. Thus, the clear correlations between dietary LC-PUFA, Δ6 desaturase expression and desaturation activity that have been observed in salmon, with reduced expression and activity in fish fed EPA-and DHA-rich fish oil compared to fish fed vegetable oils lacking LC-PUFA (Tocher et al., 2003b; Zheng et al., 2005a,b) have not been observed in cod (Tocher et al., 2006) . Therefore, if SREBPs are involved, the molecular mechanism(s) underpinning the difference in LC-PUFA sensitivity between salmon and cod are unclear as both show conserved SREs in the Δ6 FAD gene promoters. This further highlights the importance of the identification and isolation of the relevant piscine transcription factors that will be required to elucidate the effects of LC-PUFA on salmon and cod FAD promoters. Finally, the EMSA results were positive in as much as the AS cell nuclear extract was shown to contain proteins that did bind to promoter regions, sites 3 (a possible C/EBPα site) and 5 (Sp1) in cod and salmon, respectively, that were shown to possess significant activity. However, purified piscine factors will also greatly enhance the insight that EMSA could provide to elucidating the complex mechanisms of gene regulation in fish.
In conclusion, deletion analysis of Δ6 FAD promoters in Atlantic salmon and Atlantic cod identified specific regions of 5' sequence that had promoter activity in a transfected salmon cell line. These areas were also identified as the areas associated with EPA-suppression of expression and are highly conserved across diverse vertebrates, indicating potentially common regulatory mechanisms. In addition though, a site was identified in salmon with similarity to that recognised by Sp1 transcription factor, and which was required for full expression of the salmon Δ6 FAD gene. In contrast, the cod promoter was less active and lacked the Sp1 site. The study represents the first report of functional promoter analysis of FAD genes in fish, and a further step in elucidating the molecular mechanisms of transcriptional regulation of LC-PUFA biosynthesis towards our goal of designing nutritional strategies to enhance and/or optimise the activity of the pathway in fish. (Zar, 1984) . ANOVA followed by Scheffe's test (Zar, 1984) . followed by Scheffe's test (Zar, 1984) . were incubated with biotin labelled probe for site 5 (Sp1) (lanes 2, 3, 7, 8 and 9) or biotin labelled mutated site 5 probe (lanes 5 and 6). Unlabelled self probes were used as competitor DNA. Band A was the shifted DNA-protein complexes. Band B was the free probe. 
